International Journal of Pediatrics of rheumatic fever: a statement for health professionals,” Pediatrics, vol. 96, no. 4, pp. 758–764, 1995. [5] M. E. Pichichero, J. L. Green, A. B. Francis, et al., “Recurrent group A streptococcal tonsillopharyngitis,” Pediatric Infectious Disease Journal, vol. 17, no. 9, pp. 809–815, 1998. [6] J. R. Casey, “Selecting the optimal antibiotic in the treatment of group A β-hemolytic streptococci pharyngitis,” Clinical Pediatrics, vol. 46, supplement 4, pp. 25S–35S, 2007. [7] M. E. Pichichero, J. R. Casey, T. Mayes, et al., “Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies,” Pediatric Infectious Disease Journal, vol. 19, no. 9, pp. 917–923, 2000. [8] E. L. Kaplan and D. R. Johnson, “Unexplained reduced micro- biological eﬃcacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis,” Pediatrics, vol. 108, no. 5, pp. 1180–1186, 2001. [9] I. Brook, “Penicillin failure in the treatment of acute and relapsing tonsillopharyngitis is associated with copathogens and alteration of microbial balance: a role for cephalosporins,” Clinical Pediatrics, vol. 46, supplement 4, pp. 17S–24S, 2007. [10] M. E. Pichichero, F. A. Disney, G. H. Aronovitz, C. Ginsburg, and M. Stillerman, “A multicenter, randomized, single-blind evaluation of cefuroxime axetil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis,” Clinical Pedi- atrics, vol. 26, no. 9, pp. 453–458, 1987. [11] D. Adam, H. Scholz, and M. Helmerking, “Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststrep- tococcal sequelae,” Journal of Infectious Diseases, vol. 182, no. 2, pp. 509–516, 2000. [12] J. R. Casey and M. E. Pichichero, “Meta-analysis of cephalosporin versus penicillin treatment of group A strepto- coccal tonsillopharyngitis in children,” Pediatrics, vol. 113, no. 4, pp. 866–882, 2004. [13] J. R. Casey and M. E. Pichichero, “Metaanalysis of short course antibiotic treatment for group A streptococcal tonsillopharyn- gitis,” Pediatric Infectious Disease Journal, vol. 24, no. 10, pp. 909–917, 2005. [14] S. T. Shulman, M. A. Gerber, R. R. Tanz, and M. Markowitz, “Streptococcal pharyngitis: the case for penicillin therapy,” Pediatric Infectious Disease Journal, vol. 13, no. 1, pp. 1–7, 1994. [15] M. A. Gerber, R. R. Tanz, W. Kabat, et al., “Potential mechanisms for failure to eradicate group A streptococci from the pharynx,” Pediatrics, vol. 104, no. 4, pp. 911–917, 1999. [16] S. T. Shulman and M. A. Gerber, “So what’s wrong with penicillin for strep throat?” Pediatrics, vol. 113, no. 6, pp. 1816–1819, 2004. [17] J. M. Martin, M. Green, K. A. Barbadora, and E. R. Wald, “Group a streptococci among school-aged children: clinical characteristics and the carrier state,” Pediatrics, vol. 114, no. 5, pp. 1212–1219, 2004. [18] S. Holm, C. Henning, E. Grahn, H. Lomberg, and H. Staley, “Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children,” Scandinavian Journal of Infectious Diseases, vol. 27, no. 3, pp. 221–228, 1995. [19] M. Pichichero and J. R. Casey, “Deﬁning and dealing with carriers of group A streptococci,” Contemporary Pediatrics, vol. 20, no. 1, pp. 46–57, 2003. 5